Login or Sign Up
15:48 Dec 12
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd. Deals
Concord Biotech Ltd.
Industry Biotechnology
15:48 Dec 12
Quality
64/100
High Financial Strength
Valuation
26/100
Expensive Valuation
Technical
30/100
Technically Bearish
Strength
8
Weakness
7
Opportunity
0
Threats
1
0.78 %
Dividend Yield
14.33K
Market Cap (Cr)
37.41
RSI
44.08 %
Promoter Holding
30.96 %
Net Profit Margin
| Client | Date | Avg Price | Qty | Value(Cr) | Action |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully